Men who carry BRCA mutations are at a higher risk of developing prostate cancer, particularly those with the BRCA2 gene which is associated with a more aggressive form of the disease. BRCA1 and BRCA2 are tumor suppressor genes that are inherited in an autosomal dominant manner with incomplete penetrance. On the other hand, APC mutation is not a major contributor to the development of clinical prostate cancer, as it is primarily responsible for colorectal tumors, often accompanied by ras and p53 mutations. BRAF mutation is an incorrect answer, as it is rare in both early and late-stage prostate cancer, but is found in approximately 50% of melanomas.

Understanding Tumour Suppressor Genes

Tumour suppressor genes are responsible for controlling the cell cycle and preventing the development of cancer. When these genes lose their function, the risk of cancer increases. However, it is important to note that both alleles of the gene must be mutated before cancer can occur.

There are several examples of tumour suppressor genes, including p53, APC, BRCA1 & BRCA2, NF1, Rb, WT1, and MTS-1 (p16). These genes are associated with various types of cancer, such as colorectal cancer, breast and ovarian cancer, neurofibromatosis, retinoblastoma, Wilm’s tumour, and melanoma.

It is crucial to understand the role of tumour suppressor genes in preventing cancer and the consequences of their loss of function. In contrast to oncogenes, which result in an increased risk of cancer due to a gain of function, tumour suppressor genes must be both mutated before cancer can occur. By studying these genes and their functions, researchers can develop new strategies for cancer prevention and treatment.

If a patient was assigned male at birth and is undergoing treatment with oestradiol, GNRH analogs, finasteride or cyproterone, there may be a decrease or cessation of sperm production. However, this cannot be considered a reliable method of contraception. In the case of a trans female patient, who was assigned male at birth, hormonal treatments cannot be relied upon for contraception. There is a possibility of her female partner becoming pregnant, and therefore, barrier methods are recommended. Hormonal contraceptives are not suitable for this patient, and the copper IUD is not an option as she does not have a uterus.

Contraceptive and Sexual Health Guidance for Transgender and Non-Binary Individuals

The Faculty of Sexual & Reproductive Healthcare has released guidance on contraceptive choices and sexual health for transgender and non-binary individuals. The guidance emphasizes the importance of sensitive communication and offering options that consider personal preferences, co-morbidities, and current medications or therapies.

For individuals engaging in vaginal sex where there may be a risk of pregnancy and/or sexually transmitted infections, condoms and dental dams are recommended. Cervical screening and human papillomavirus vaccinations should also be offered to sexually active individuals with a uterus. Those engaging in anal sex and rimming should be advised of the risk of hepatitis A & B and offered vaccinations. Individuals at risk of HIV transmission should be advised of the availability of pre-exposure prophylaxis and post-exposure prophylaxis as required.

For patients seeking permanent contraception, a fallopian tube occlusion or a vasectomy may be the most appropriate solution and neither would be affected by hormonal therapy. Testosterone therapy does not provide protection against pregnancy, and oestrogen-containing regimes are not recommended in patients undergoing testosterone therapy. Progesterone-only contraceptives are considered safe, and the intrauterine system and injections may also suspend menstruation. Non-hormonal intrauterine devices do not interact with hormonal regimes but can exacerbate menstrual bleeding.

In patients assigned male at birth, there may be a reduction or cessation of sperm production with certain therapies, but the variability of effects means they cannot be relied upon as a method of contraception. Condoms should be recommended in those patients engaging in vaginal sex wishing to avoid the risk of pregnancy. Emergency contraception may be required in patients assigned female at birth following unprotected vaginal intercourse, and either of the available oral emergency contraceptive options may be considered. The non-hormonal intrauterine device may also be an option, but it may have unacceptable side effects in some patients.

Overall, the guidance stresses the importance of individualized care and communication in contraceptive and sexual health decisions for transgender and non-binary individuals.

If a patient has a known allergy to a sulfa drug like co-trimoxazole, they should avoid taking sulfasalazine.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is a serious condition that can occur with the long-term use of certain antipsychotic drugs. It is important to consider NMS as a potential cause of deterioration in patients taking these drugs, especially if there has been a recent increase in dosage. Unfortunately, NMS is often misdiagnosed as it can mimic other conditions, including the underlying psychiatric disorder. NMS is caused by changes in dopamine levels in the brain and the release of calcium from muscle cells. This occurs due to activation of the ryanodine receptor, which causes high metabolic activity in muscles, leading to hyperpyrexia and rhabdomyolysis.

Symptoms of NMS include extreme muscle rigidity, parkinsonism, and high fever. Patients may also experience confusion, fluctuations in consciousness, and autonomic instability. Treatment for NMS involves IV fluid rehydration, dantrolene, and bromocriptine. It is important to differentiate NMS from other conditions, such as sepsis or asthma exacerbation, through careful examination and testing. Discontinuation of the offending drug is mandatory, and patients may require prolonged ITU admissions.

In conclusion, NMS is a potentially life-threatening condition that can occur with the use of certain antipsychotic drugs. It is important to consider NMS as a potential cause of deterioration in patients taking these drugs and to differentiate it from other conditions through careful examination and testing. Treatment for NMS involves supportive care and discontinuation of the offending drug.

Understanding Neuroleptic Malignant Syndrome: A Potentially Life-Threatening Reaction to Neuroleptic Medication

Neuroleptic malignant syndrome (NMS) is a rare but serious reaction to neuroleptic medication. It is characterized by hyperpyrexia (high fever), autonomic dysfunction, rigidity, altered consciousness, and elevated creatine phosphokinase levels. Treatment involves stopping the neuroleptic medication and cooling the patient. Medications such as bromocriptine, dantrolene, and benzodiazepines may also be used.

It is important to note that other conditions, such as cerebral abscess, meningitis, and phaeochromocytoma, do not typically present with the same symptoms as NMS. Serotonin syndrome, while similar, usually presents with different symptoms such as disseminated intravascular coagulation, renal failure, tachycardia, hypertension, and tachypnea.

If you or someone you know is taking neuroleptic medication and experiences symptoms of NMS, seek medical attention immediately. Early recognition and treatment can be life-saving.

Understanding Roseola Infantum

Roseola infantum, also known as exanthem subitum or sixth disease, is a common illness that affects infants and is caused by the human herpes virus 6 (HHV6). This disease has an incubation period of 5-15 days and is typically seen in children aged 6 months to 2 years. The most common symptoms of roseola infantum include a high fever that lasts for a few days, followed by a maculopapular rash. Other symptoms may include Nagayama spots, which are papular enanthems on the uvula and soft palate, as well as cough and diarrhea.

In some cases, febrile convulsions may occur in around 10-15% of children with roseola infantum. While this can be concerning for parents, it is important to note that this is a common occurrence and typically resolves on its own. Additionally, HHV6 infection can lead to other possible consequences such as aseptic meningitis and hepatitis.

It is important to note that school exclusion is not necessary for children with roseola infantum. While this illness can be uncomfortable for infants, it is typically not serious and resolves on its own within a few days.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

The symptoms and high ESR levels suggest that the patient may have polymyalgia rheumatica, with the added indication of painful mastication pointing towards possible temporal arthritis. Immediate treatment with high doses of steroids is crucial. To distinguish between polymyalgia rheumatica and statin-induced myopathy, ESR levels are typically measured. A significantly elevated ESR level would indicate polymyalgia rheumatica, while a normal ESR level would suggest statin myopathy.

Polymyalgia Rheumatica: A Condition of Muscle Stiffness in Older People

Polymyalgia rheumatica (PMR) is a common condition that affects older people. It is characterized by muscle stiffness and elevated inflammatory markers. Although it is closely related to temporal arthritis, the underlying cause is not fully understood, and it does not appear to be a vasculitic process. PMR typically affects patients over the age of 60 and has a rapid onset, usually within a month. Patients experience aching and morning stiffness in proximal limb muscles, along with mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, and night sweats.

To diagnose PMR, doctors look for raised inflammatory markers, such as an ESR of over 40 mm/hr. Creatine kinase and EMG are normal. Treatment for PMR involves prednisolone, usually at a dose of 15 mg/od. Patients typically respond dramatically to steroids, and failure to do so should prompt consideration of an alternative diagnosis.

Diabetic Nephropathy and the Benefits of ACE Inhibitors

Diabetic nephropathy is a clinical condition characterized by persistent albuminuria, a decline in the glomerular filtration rate, and elevated arterial blood pressure. To confirm the diagnosis, albuminuria must be present on at least two occasions three to six months apart. Antihypertensive therapy can slow the progression of diabetic glomerulopathy, but ACE inhibitors have been shown to provide superior long-term protection.

Aside from its cardiovascular benefits, ACE inhibition has also been found to have a significant positive effect on the progression of diabetic retinopathy and the development of proliferative retinopathy. Therefore, ACE inhibitors are a recommended treatment option for patients with diabetic nephropathy. By this condition and the benefits of ACE inhibitors, healthcare professionals can provide better care for their patients with diabetes.

Due to the patient’s history, there is a potential for urethral injury, therefore, urethral catheterisation should not be performed.

Lower Genitourinary Tract Trauma: Types of Injury and Management

Lower genitourinary tract trauma can occur due to blunt trauma, with most bladder injuries associated with pelvic fractures. However, these injuries can easily be overlooked during trauma assessment. In fact, up to 10% of male pelvic fractures are associated with urethral or bladder injuries.

Urethral injuries are mainly found in males and can be identified by blood at the meatus in 50% of cases. There are two types of urethral injury: bulbar rupture and membranous rupture. Bulbar rupture is the most common and is caused by straddle-type injuries, such as those from bicycles. The triad signs of urinary retention, perineal hematoma, and blood at the meatus are indicative of this type of injury. Membranous rupture, on the other hand, can be extra or intraperitoneal and is commonly due to pelvic fractures. Penile or perineal edema/hematoma and a displaced prostate upwards are also signs of this type of injury. An ascending urethrogram is the recommended investigation, and management involves surgical placement of a suprapubic catheter.

External genitalia injuries, such as those to the penis and scrotum, can be caused by penetration, blunt trauma, continence- or sexual pleasure-enhancing devices, and mutilation.

Bladder injuries can be intra or extraperitoneal and present with haematuria or suprapubic pain. A history of pelvic fracture and inability to void should always raise suspicion of bladder or urethral injury. Inability to retrieve all fluid used to irrigate the bladder through a Foley catheter is also indicative of bladder injury. An IVU or cystogram is the recommended investigation, and management involves laparotomy if intraperitoneal and conservative treatment if extraperitoneal.

In summary, lower genitourinary tract trauma can have various types of injuries, and prompt diagnosis and management are crucial to prevent further complications.